About the Journal
Journal of Integrative Cancer Biology is a peer-reviewed, international, open-access journal dedicated to advancing a comprehensive and interdisciplinary understanding of cancer biology and its translation into clinical practice. The journal provides a global platform for researchers, clinicians, and healthcare innovators working at the intersection of molecular biology, systems biology, translational oncology, and patient-centered cancer research. By integrating discoveries from laboratory science with clinical insights and population-level data, the journal aims to accelerate progress in cancer prevention, diagnosis, and therapy. As cancer research continues to evolve toward multi-omics integration, precision medicine, and cross-disciplinary collaboration, Journal of Integrative Cancer Biology offers a dedicated venue for studies that bridge fundamental biological discoveries with real-world clinical impact. We welcome original research articles, comprehensive reviews, meta-analyses, clinical investigations, computational studies, and translational research that enhance understanding of tumor development, progression, and therapeutic response.
Aim and Scope
Journal of Integrative Cancer Biology publishes high-quality original research articles, reviews, short communications, case reports, and clinical perspectives that explore cancer through multidisciplinary, systems-level, and translational approaches. The journal emphasizes integration of molecular, clinical, computational, and population sciences to advance a holistic understanding of cancer biology and oncology practice.
Integrative Medical, Surgical & Radiation Oncology
- Combined modality therapies and multidisciplinary treatment strategies
- Integration of chemotherapy, radiotherapy, immunotherapy, and targeted therapy
- Precision oncology, pharmacogenomics, and data-driven personalized medicine
- Image-guided, minimally invasive, and robotic cancer surgeries
- Treatment toxicity prediction, supportive oncology, and survivorship integration
Integrative Hematologic Oncology
- Leukemia, lymphoma, myeloma, and myeloproliferative disorders
- Bone marrow transplantation, cellular therapy, and immune reconstitution
- Molecular diagnostics, imaging, and integrated classification of blood cancers
- CAR-T therapy, gene editing, and next-generation immunotherapies
Integrative Cancer Biology & Tumor Microenvironment
- Systems-level understanding of carcinogenesis and tumor progression
- Tumor microenvironment interactions, angiogenesis, metastasis, and immune modulation
- Cancer stem cells, signaling networks, and epigenetic regulation Multi-omics integration (genomics, proteomics, metabolomics, transcriptomics)
- Biomarker discovery through integrative and computational approaches
Cancer Immunology & Immunotherapy
- Immune checkpoint inhibitors, vaccines, monoclonal antibodies
- Tumor-infiltrating lymphocytes, cytokine therapy, and NK-cell research
- Immune microenvironment profiling and immune-escape mechanisms
- Emerging immunotherapeutic technologies and clinical application
Cancer Prevention, Screening & Early Detection
- Population-based cancer screening programs and diagnostic innovations
- Lifestyle, environmental, and genetic risk factors
- Early detection biomarkers, liquid biopsy, and advanced imaging
- Public health strategies and preventive oncology
Translational & Experimental Oncology
- Preclinical drug discovery, nanomedicine, and experimental therapeutics
- Organoids, 3D models, xenografts, and animal models of cancer Mechanistic studies, pathway targeting, and drug resistance research
- Translational approaches bridging laboratory findings to clinical practice
Psycho-Oncology, Survivorship & Palliative Care
- Quality of life, symptom management, and long-term survivorship
- Psychosocial oncology, mental health, and caregiver support
- Pain management, end-of-life care, and palliative interventions
- Rehabilitation, nutrition, and holistic cancer care
Oncology Technology, AI & Innovations
- AI/ML in cancer diagnosis, prognosis, and treatment planning
- Radiomics, digital pathology, and computational oncology
- Wearables, remote monitoring, and tele-oncology applications
Editorial and Peer-Review Policy
Journal of Integrative Cancer Biology employs a single-blind peer-review process to maintain fairness,
scientific integrity, and the quality of published work.
Key Features:
- Each manuscript is reviewed by independent experts in the relevant field, along with oversight from an academic editor.
- Reviewers can see author details, but the identities of the reviewers remain hidden from the authors.
- The review criteria focus on originality, technical strength, methodological accuracy, ethical compliance, clarity, and relevance to the field of Journal of Integrative Cancer Biology.
- All submissions go through plagiarism checks and ethical evaluations before the peer-review process.
- Final decisions on publication are made by the handling editor, based on the reviewers' evaluations and the overall quality of the manuscript.
Publication Frequency & Format
This journal comes out Bi-Annual (Two issues per year). Once articles are accepted, they're quickly made available online in both HTML and PDF formats, ensuring fast and easy access to research findings.
Open Access Policy
Journal of Integrative Cancer Biology embraces a gold open access model, meaning all published articles are freely accessible to everyone. Authors retain the copyright to their work, shared under a suitable open-access license to promote transparency, collaboration, and global knowledge-sharing.
Indexing & Archiving
The journal aims to be included in well-known scientific indexing and abstracting databases. All content is preserved through trusted archiving systems to ensure long-term accessibility and discoverability.
For Manuscript Submission
Authors can submit their manuscripts through the journal's Online Submission System
(Submit Manuscript) or by emailing the Editorial Office at
support@confmeets.com.
Submitted manuscripts must adhere to the Journal of Integrative Cancer Biology Author Guidelines, which cover structure, formatting,
ethical approvals, and conflict-of-interest disclosures.
Publication Ethics & Integrity
Journal of Integrative Cancer Biology is committed to maintaining the highest publication ethics standards in accordance with COPE principles.
Authors must ensure proper ethical approvals for studies involving humans, animals, or sensitive materials, and follow informed consent and confidentiality practices.
They must also disclose conflicts of interest and funding support, report data accurately, and acknowledge contributor roles.
All submissions undergo plagiarism checks, and the journal has a strict policy for corrections, retractions, and post-publication updates.
